You have 9 free searches left this month | for more free features.

Co-diagnosed NERD

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Duvelisib, Chidamide
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Jul 27, 2023

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Diabetic Macular Edema, Pars Plana Vitrectomy, Dexamethasone Intravitreal Implant Trial in Tianjin (Ozurdex, Aflibercept)

Not yet recruiting
  • Diabetic Macular Edema
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Aug 6, 2023

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

Parkinson Disease Trial (KEEP Intervention, control)

Not yet recruiting
  • Parkinson Disease
  • KEEP Intervention
  • control
  • (no location specified)
Feb 11, 2022

Multiple Myeloma Trial in Shanghai (GC012F injection)

Not yet recruiting
  • Multiple Myeloma
  • GC012F injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
May 1, 2023

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

The Proportion of Patients Diagnosed With Dry Eye by Asia Dry

Active, not recruiting
  • Dry Eye Syndromes
  • No intervention
  • Kaohsiung city, Taiwan
  • +2 more
May 25, 2022

Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • (no location specified)
Dec 22, 2022

Multiple Myeloma Trial in Shanghai (GC012F injection)

Recruiting
  • Multiple Myeloma
  • GC012F injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Aug 1, 2022

Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Esophageal Reflux Disease Trial in Iksan

Recruiting
  • Non-erosive Reflux Disease
  • +2 more
  • DWP14012 20mg
  • +2 more
  • Iksan, Jeollabuk-do, Korea, Republic of
    Wonkwang University Hospital
Nov 6, 2023

Oligodendroglioma Trial in Germany (CETEG, PCV, RT)

Recruiting
  • Oligodendroglioma
  • Heidelberg, Baden-Württemberg, Germany
  • +18 more
Sep 22, 2022

MGMT-Unmethylated Glioblastoma Trial in Nanjing (Anlotinib, AK105, Radiotherapy)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 27, 2021

MDD Co-Occurrent With Anxiety, Adult Patients, Newly Diagnosed Depression Trial in Czechia

Recruiting
  • Major Depressive Disorder Co-Occurrent With Anxiety
  • +2 more
    • Brno, Czechia
    • +5 more
    Jan 31, 2023

    AL Amyloidosis Trial (procedure, drug, other)

    Not yet recruiting
    • AL Amyloidosis
    • Autologous Hematopoietic Stem Cell Transplantation
    • +15 more
    • (no location specified)
    Aug 28, 2023

    Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

    Not yet recruiting
    • Primary Immune Thrombocytopenia
    • 2.5mg/d Hetrombopag
    • (no location specified)
    Mar 28, 2022

    Multiple Myeloma Trial in Suzhou (clarithromycin, lenalidomide, dexamethasone and autologous BCMA-directed CAR T-cells)

    Recruiting
    • Multiple Myeloma
    • clarithromycin, lenalidomide, dexamethasone and autologous BCMA-directed CAR T-cells
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Oct 22, 2021

    Non-erosive Reflux Disease, Diarrhea-Predominant Irritable Bowel Syndrome Trial in Beijing (WPQW granule, WPQW granule simulant)

    Recruiting
    • Non-erosive Reflux Disease
    • Diarrhea-Predominant Irritable Bowel Syndrome
    • WPQW granule
    • WPQW granule simulant
    • Beijing, Beijing, China
      Xiyuan Hospital of China Academy of Chinese Medical Sciences
    May 10, 2022

    Non-erosive Reflux Disease, Gastroesophageal Reflux Trial in New Orleans (Proton Pump Inhibitor (PPI) Therapy, Sucralfate)

    Terminated
    • Non-erosive Reflux Disease
    • Gastroesophageal Reflux
    • New Orleans, Louisiana
    • +1 more
    Jan 25, 2022

    Glioblastoma Trial in Beijing (Camrelizumab, radiation, Temozolomide)

    Recruiting
    • Glioblastoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Nov 25, 2020

    Necrotizing Soft Tissue Infections Trial in United States (AB103, Placebo)

    Completed
    • Necrotizing Soft Tissue Infections
    • Los Angeles, California
    • +6 more
    Jul 26, 2021

    Artificial Intelligence for Detecting Retinal Diseases

    Completed
    • Artificial Intelligence
    • Retinal Diseases
    • Retinal diseases diagnosed by artificial intelligence algorithm
    • Beijing, Beijing, China
      Wen-Bin Wei
    Apr 12, 2021

    Temporomandibular Disorder, Forward Head Posture Trial in Sharjah (Conservative with Denneroll, Conservative, Dental management)

    Not yet recruiting
    • Temporomandibular Disorder
    • Forward Head Posture
    • Conservative with Denneroll
    • +2 more
    • Sharjah, United Arab Emirates
      University of Sharjah
    Nov 24, 2023

    Temporomandibular Disorder, Forward Head Posture Trial in Sharjah (Denneroll cervical traction orthodontic, stretching and

    Not yet recruiting
    • Temporomandibular Disorder
    • Forward Head Posture
    • Denneroll cervical traction orthodontic
    • +2 more
    • Sharjah, United Arab Emirates
      University of Sharjah
    Nov 8, 2023

    AI Classifies Multi-Retinal Diseases

    Unknown status
    • Deep Learning
    • Retinal Diseases
    • Retinal multi-diseases diagnosed by DL algorithm
    • Retinal multi-diseases diagnosed by expert panel
    • Beijing, Beijing, China
      Wen-Bin Wei
    Dec 9, 2020